Metalcaptase® 150 mg

Active substance:


ATC-Code :


Pharmaceutical form:

enteric coated tablet

Therapeutic indications:

  • Morbus Wilson
  • Lead, mercury, copper and zinc poisoning
  • Rheumatoid arthritis
  • Cystinuria with detected cysteine stones when recurrence of stones cannot be prevented by other methods (methionine-free diet, hyperhydration, alkalisation of Urine) as well as in cases of advanced cysteine stone disorders invólving Special risks (e.g. after nephrectomy).
  • There is some evidence that scleroderma may respond to treatment with Metalcaptase 150 mg.